These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30021209)

  • 1. Fibroblast Growth Factor 9 Suppresses Striatal Cell Death Dominantly Through ERK Signaling in Huntington's Disease.
    Yusuf IO; Cheng PH; Chen HM; Chang YF; Chang CY; Yang HI; Lin CW; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
    Cell Physiol Biochem; 2018; 48(2):605-617. PubMed ID: 30021209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington's disease cells.
    Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
    Life Sci; 2021 Feb; 267():118952. PubMed ID: 33383048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.
    Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
    Free Radic Biol Med; 2019 Jan; 130():256-266. PubMed ID: 30391672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington's Disease Models.
    Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
    Mol Neurobiol; 2021 May; 58(5):2396-2406. PubMed ID: 33421017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 9 activates akt and MAPK pathways to stimulate steroidogenesis in mouse leydig cells.
    Lai MS; Cheng YS; Chen PR; Tsai SJ; Huang BM
    PLoS One; 2014; 9(3):e90243. PubMed ID: 24603862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial-derived neurotrophic factor (GDNF) prevents ethanol (EtOH) induced B92 glial cell death by both PI3K/AKT and MEK/ERK signaling pathways.
    Villegas SN; Njaine B; Linden R; Carri NG
    Brain Res Bull; 2006 Dec; 71(1-3):116-26. PubMed ID: 17113937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation.
    Chuang JI; Huang JY; Tsai SJ; Sun HS; Yang SH; Chuang PC; Huang BM; Ching CH
    Free Radic Biol Med; 2015 Dec; 89():274-86. PubMed ID: 26424114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of phosphatidylinositol 3-kinase/Akt on basic fibroblast growth factor-induced glial cell line-derived neurotrophic factor release from rat glioma cells.
    Tanabe K; Matsushima-Nishiwaki R; Iida M; Kozawa O; Iida H
    Brain Res; 2012 Jun; 1463():21-9. PubMed ID: 22575563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
    Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
    Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of metabolism rescue cell death in Huntington's disease models.
    Varma H; Cheng R; Voisine C; Hart AC; Stockwell BR
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14525-30. PubMed ID: 17726098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the expression of extracellular regulated kinase (ERK 1/2) in the R6/2 mouse model of Huntington's disease after phosphodiesterase IV inhibition.
    Fusco FR; Anzilotti S; Giampà C; Dato C; Laurenti D; Leuti A; Colucci D'Amato L; Perrone L; Bernardi G; Melone MA
    Neurobiol Dis; 2012 Apr; 46(1):225-33. PubMed ID: 22311347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle.
    Totty ML; Morrell BC; Spicer LJ
    Mol Cell Endocrinol; 2017 Jan; 440():25-33. PubMed ID: 27816766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.
    Wehner AB; Milen AM; Albin RL; Pierchala BA
    Neuroscience; 2016 Jun; 324():297-306. PubMed ID: 26947127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 ameliorates cell death features in Huntington's disease striatal cell models.
    Rosenstock TR; de Brito OM; Lombardi V; Louros S; Ribeiro M; Almeida S; Ferreira IL; Oliveira CR; Rego AC
    Neurochem Int; 2011 Oct; 59(5):600-9. PubMed ID: 21703318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Activation Gi/o Protein Increases Glial Cell Line-Derived Neurotrophic Factor Production through Fibroblast Growth Factor Receptor and Extracellular Signal-Regulated Kinase Pathway in Primary Cultured Rat Cortical Astrocytes.
    Hisaoka-Nakashima K; Matsumoto C; Azuma H; Taki S; Takebayashi M; Nakata Y; Morioka N
    Biol Pharm Bull; 2017; 40(10):1759-1766. PubMed ID: 28966248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
    Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
    Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.